Zenith new VP

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

frohlir944

Rank: Mail Room [?]

Points: 80 [?]

Votes: 2 Score: 5.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Zenith new VP

posted on Jul 28, 2017 11:55PM

Executive search firm Toft Group has placed Dr. Edward van der Horst as Vice President, Discovery Biology & Pre-Clinical Development at Zenith Epigenetics

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply